Swiss manufacturer of Class II & III Medical Devices for autologous blood cell preparations, hyaluronic acid, adipose tissue and bone marrow cell extracts.

Image is not available
What is A-PRP® ?

The patient’s platelet concentrate prepared with RegenKit®.
Platelets are key factors in hard and soft tissue repair mechanisms. They provide essential growth factors, such as FGF, PDGF, TGF-ß, EGF, VEGF, IGF, which are involved in stem cell migration, using the patient's own blood, there is no risk of allergy or rejection.

Image is not available
Image is not available
Image is not available
Image is not available
TECHNOLOGY PLATFORM FOR INTRA & SUB DERMAL PROCEDURES
SkinVisc 40
Regenkit A-PRP
Cellular Matrix
RegenExtracell
Adipcytes
Image is not available
TECHNOLOGY PLATFORM FOR MSK PAIN, INJURIES & TRAUMA PROCEDURES
Image is not available
Image is not available
Image is not available
ArthoVisc 40
Regenkit A-PRP
Cellular Matrix
RegenExtracell
BMC & GLUE
Image is not available
previous arrow
next arrow
Shadow
Slider

​Regen Lab Difference


Our Technologies

SkinVisc / ArthroVisc HA
RegenKit® A-PRP
CellularMatrix™ A-PRP & HA
RegenExtracell® BMC / Adipocytes

Therapeutic Areas

Orthopaedics
Skin Care
Chronic Wounds
Sports Medicine
Bone Reconstruction
Hair Regeneration
Plastic Surgery
Veterinary

Quality Products 

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance. Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

About Us


Since 2003, Regen Lab SA has been committed to the development of a unique expertise for the design and manufacturing of high-quality medical devices, intended for cells therapies and for the preparation of autologous platelet-rich plasma (PRP) from the patient’s own blood, to be used in bedside procedures.

Regen Lab SA manufactures several CE-marked products to fit to medical disciplines where PRP represents a treatment option. ​Patients ​can ​expect very good outcomes for the treatment of their chronic and surgical wounds, dry eye syndrome and other ophthalmic conditions, sport-related wounds and even alopecia, as demonstrated through the clinical studies Regen Lab has ​set-up over the past few years.

In the last five years, over 2​ million patients have been treated using Regen Lab products and another 10​ thousand have benefited from bone marrow stem cell kits. The company ​invested in a new Good Manufacturing Practice (GMP) facility located at the Mont-sur-Lausanne (canton of Vaud) ​beginning production ​in 2017. It is planned that this new peak performance industrial platform will allow the treatment of over 1​ million patients ​per year.

Regen Lab SA manufactures several CE-marked products to fit to medical disciplines where PRP represents a treatment option. Thus, patients are allowed to expect very good outcomes for the treatment of their chronic and surgical wounds, dry eye syndrome and other ophthalmic conditions, sport-related wounds and even alopecia, as demonstrated through the clinical studies Regen Lab has strived to set-up over the past few years.



In the last five years, over 2’000’000 patients have been treated using Regen Lab products and another 10’000 have benefited from bone marrow stem cell kits. The company has now invested in a new GMP (Good Manufacturing Practice) facility located at the Mont-sur-Lausanne (canton of Vaud) the production of which is set to start in 2017. It is planned that this new peak performance industrial platform will allow the treatment of over 1’000’000 patients a year.

Our Regional Offices


Our Regional offices are located in New York (USA), Montreal (Canada), Venice (Italy), Munich (Germany), Paris (France), Dubai (U.A.E.) and Beijing (China).

Partners and Affiliations

previous arrow
next arrow
Slider

Latest News

Face, Neck and Decollete ; Alopecia Training
Workshop BioBridge "Introductory" Face, Neck and Decollete ; Alopecia Thursday March 1st 2018 15h - 19h Aesthetic Clinic Geneve 50[...]
1st BioBridge Middle East – 28 Jan, 2018
​ We are very pleased to confirm that the BioBridge Foundation will host its 1st Middle East BioBridge Foundation Conference[...]
IMCAS 1-3 Feb, 2018
Regen Lab is official sponsor of the Lipofilling and Stem Cells ​Module  2 February 2018 from 08:00 - 18:30,  Room 4 With the[...]

Notice!

Some of the information contained on this website pertains to products, indications for use of products and / or therapies that are only available outside the United States and have not been approved or cleared for marketing by the United States Food & Drug Administration (FDA).